Cargando…
Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation
Ischemic cerebral infarction represents a significant cause of disability and death worldwide. Caspase-1 is activated by the NLRP3/ASC pathway and inflammasomes, thus triggering pyroptosis, a programmed cell death. In particular, this death is mediated by gasdermin D (GSDMD), which induces secretion...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874210/ https://www.ncbi.nlm.nih.gov/pubmed/33584203 http://dx.doi.org/10.3389/fncel.2020.540669 |
_version_ | 1783649545538764800 |
---|---|
author | Liang, Yubin Song, Pingping Chen, Wei Xie, Xuemin Luo, Rixin Su, Jiehua Zhu, Yunhui Xu, Jiamin Liu, Rongrong Zhu, Peizhi Zhang, Yusheng Huang, Min |
author_facet | Liang, Yubin Song, Pingping Chen, Wei Xie, Xuemin Luo, Rixin Su, Jiehua Zhu, Yunhui Xu, Jiamin Liu, Rongrong Zhu, Peizhi Zhang, Yusheng Huang, Min |
author_sort | Liang, Yubin |
collection | PubMed |
description | Ischemic cerebral infarction represents a significant cause of disability and death worldwide. Caspase-1 is activated by the NLRP3/ASC pathway and inflammasomes, thus triggering pyroptosis, a programmed cell death. In particular, this death is mediated by gasdermin D (GSDMD), which induces secretion of interleukin (IL)-1β and IL-18. Accordingly, inhibition of caspase-1 prevents the development and worsening of multiple neurodegenerative diseases. However, it is not clear whether inhibition of caspase-1 can preserve blood-brain barrier (BBB) integrity following cerebral infarction. This study therefore aimed at understanding the effect of caspase-1 on BBB dysfunction and its underlying mechanisms in permanent middle cerebral artery occlusion (MCAO). Our findings in rat models revealed that expression of caspase-1 was upregulated following MCAO-induced injury in rats. Consequently, pharmacologic inhibition of caspase-1 using vx-765 ameliorated ischemia-induced infarction, neurological deficits, and neuronal injury. Furthermore, inhibition of caspase-1 enhanced the encapsulation rate of pericytes at the ischemic edge, decreased leakage of both Evans Blue (EB) and matrix metalloproteinase (MMP) proteins, and upregulated the levels of tight junctions (TJs) and tissue inhibitors of metalloproteinases (TIMPs) in MCAO-injured rats. This in turn improved the permeability of the BBB. Meanwhile, vx-765 blocked the activation of ischemia-induced pyroptosis and reduced the expression level of inflammatory factors such as caspase-1, NLRP3, ASC, GSDMD, IL-1β, and IL-18. Similarly, vx-765 treatment significantly reduced the expression levels of inflammation-related receptor for advanced glycation end products (RAGE), high-mobility family box 1 (HMGB1), mitogen-activated protein kinase (MAPK), and nuclear factor-κB (NF-κB). Evidently, inhibition of caspase-1 significantly improves ischemia-associated BBB permeability and integrity by suppressing pyroptosis activation and the RAGE/MAPK pathway. |
format | Online Article Text |
id | pubmed-7874210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78742102021-02-11 Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation Liang, Yubin Song, Pingping Chen, Wei Xie, Xuemin Luo, Rixin Su, Jiehua Zhu, Yunhui Xu, Jiamin Liu, Rongrong Zhu, Peizhi Zhang, Yusheng Huang, Min Front Cell Neurosci Cellular Neuroscience Ischemic cerebral infarction represents a significant cause of disability and death worldwide. Caspase-1 is activated by the NLRP3/ASC pathway and inflammasomes, thus triggering pyroptosis, a programmed cell death. In particular, this death is mediated by gasdermin D (GSDMD), which induces secretion of interleukin (IL)-1β and IL-18. Accordingly, inhibition of caspase-1 prevents the development and worsening of multiple neurodegenerative diseases. However, it is not clear whether inhibition of caspase-1 can preserve blood-brain barrier (BBB) integrity following cerebral infarction. This study therefore aimed at understanding the effect of caspase-1 on BBB dysfunction and its underlying mechanisms in permanent middle cerebral artery occlusion (MCAO). Our findings in rat models revealed that expression of caspase-1 was upregulated following MCAO-induced injury in rats. Consequently, pharmacologic inhibition of caspase-1 using vx-765 ameliorated ischemia-induced infarction, neurological deficits, and neuronal injury. Furthermore, inhibition of caspase-1 enhanced the encapsulation rate of pericytes at the ischemic edge, decreased leakage of both Evans Blue (EB) and matrix metalloproteinase (MMP) proteins, and upregulated the levels of tight junctions (TJs) and tissue inhibitors of metalloproteinases (TIMPs) in MCAO-injured rats. This in turn improved the permeability of the BBB. Meanwhile, vx-765 blocked the activation of ischemia-induced pyroptosis and reduced the expression level of inflammatory factors such as caspase-1, NLRP3, ASC, GSDMD, IL-1β, and IL-18. Similarly, vx-765 treatment significantly reduced the expression levels of inflammation-related receptor for advanced glycation end products (RAGE), high-mobility family box 1 (HMGB1), mitogen-activated protein kinase (MAPK), and nuclear factor-κB (NF-κB). Evidently, inhibition of caspase-1 significantly improves ischemia-associated BBB permeability and integrity by suppressing pyroptosis activation and the RAGE/MAPK pathway. Frontiers Media S.A. 2021-01-11 /pmc/articles/PMC7874210/ /pubmed/33584203 http://dx.doi.org/10.3389/fncel.2020.540669 Text en Copyright © 2021 Liang, Song, Chen, Xie, Luo, Su, Zhu, Xu, Liu, Zhu, Zhang and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular Neuroscience Liang, Yubin Song, Pingping Chen, Wei Xie, Xuemin Luo, Rixin Su, Jiehua Zhu, Yunhui Xu, Jiamin Liu, Rongrong Zhu, Peizhi Zhang, Yusheng Huang, Min Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation |
title | Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation |
title_full | Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation |
title_fullStr | Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation |
title_full_unstemmed | Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation |
title_short | Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation |
title_sort | inhibition of caspase-1 ameliorates ischemia-associated blood-brain barrier dysfunction and integrity by suppressing pyroptosis activation |
topic | Cellular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874210/ https://www.ncbi.nlm.nih.gov/pubmed/33584203 http://dx.doi.org/10.3389/fncel.2020.540669 |
work_keys_str_mv | AT liangyubin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT songpingping inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT chenwei inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT xiexuemin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT luorixin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT sujiehua inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT zhuyunhui inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT xujiamin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT liurongrong inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT zhupeizhi inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT zhangyusheng inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation AT huangmin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation |